Quantcast

Latest Sexual dysfunction Stories

2014-03-12 23:23:25

After more than a decade of short-term cures for erectile dysfunction, most aimed at symptoms rather than the underlying issues of nerve, muscle and blood vessel damage, a new approach has emerged from adult stem cell technology developed by the DaSilva Institute, that offers hope for erectile dysfunction treatment. Sarasota, FL (PRWEB) March 12, 2014 Erectile dysfunction (ED) is the most commonly studied disorder when it comes to male sexual dysfunction. It is estimated that 18 million...

2014-03-03 08:31:34

Orexa will be the first drug ever to enter clinical trials for male HSDD JERSEY CITY, N.J., March 3, 2014 /PRNewswire/ -- S1 Biopharma today announced its plan to initiate Phase 2a clinical trials in the third quarter of this year for Orexa (S1P-205), its first-in-class therapy to treat male Hypoactive Sexual Desire Disorder (HSDD). The double-blind placebo-controlled study will be the first to evaluate a drug for male HSDD. Key points: -- Hypoactive sexual desire disorder is a sexual...

2014-02-24 08:27:59

Data from first-in-class investigational treatment presented at the International Society for the Study of Women's Sexual Health (ISSWSH) Conference in San Diego CRANBURY, N.J., Feb. 24, 2014 /PRNewswire/ -- Palatin Technologies, Inc. (NYSE MKT: PTN) presented new analyses from its Phase 2b clinical trial of bremelanotide, which demonstrated dose-dependent improvements in sexual desire and treatment satisfaction in premenopausal women with hypoactive sexual desire disorder (HSDD) and combined...

2014-02-19 08:29:55

-Company Marks Milestone of Two New Product Launches- CHESTERBROOK, Pa., Feb. 19, 2014 /PRNewswire/ -- Auxilium Pharmaceuticals, Inc. (NASDAQ: AUXL), a fully integrated specialty biopharmaceutical company, will ring the Opening Bell at the NASDAQ MarketSite in Times Square, New York at 9:30 a.m. ET on February 26, 2014 to celebrate Auxilium's transformation into a leading men's healthcare company, including two recent launches of new products in men's healthcare, XIAFLEX®...

Sexual Dysfunction Doesn't Stop A Woman From Having A Good Time
2014-02-12 04:33:10

Lee Rannals for redOrbit.com - Your Universe Online Even middle age women who have been diagnosed with sexual dysfunction continue to be sexually active, according to a new study. Researchers studied 354 middle-aged and older women who had taken a test called the Female Sexual Function Index. This test is designed to diagnose women’s sexual problems, asking questions about arousal, orgasm, vaginal lubrication and pain during intercourse. All of the women had reported being sexually...

2014-02-11 12:26:47

Women's Groups Call on FDA to Restore Gender Equity in the Treatment of Sexual Disorders WASHINGTON, Feb. 11, 2014 /PRNewswire-USNewswire/ -- In response to the U.S. Food and Drug Administration's (FDA) decision to further delay approval of the first-ever drug to treat the most common female sexual disorder, the National Consumers League and the National Organization for Women, joined by women's health and advocacy organizations, are calling on the FDA to move swiftly to end the 16...

2014-02-11 08:31:56

Agency Proposes Select Phase I Studies as Part of Resubmission RALEIGH, N.C., Feb. 11, 2014 /PRNewswire/ -- Sprout Pharmaceuticals announced today that their Formal Dispute Resolution, which was filed in December 2013, resulted in clear guidance from the FDA on the path forward. Sprout will resubmit the New Drug Application (NDA) for flibanserin, a once-daily treatment for Hypoactive Sexual Desire Disorder (HSDD) in premenopausal women, by the third quarter. The FDA has requested...

2014-01-30 08:31:26

CRANBURY, N.J., Jan. 30, 2014 /PRNewswire/ -- Palatin Technologies, Inc. (NYSE MKT: PTN) announced today that data from a 12-week placebo-controlled dose-ranging study using self-administered subcutaneous bremelanotide for the treatment of female sexual dysfunctions will be presented at the 16(th) Congress of the European Society for Sexual Medicine in Istanbul, Turkey on Friday, January 31, 2014 at 3:25 PM local time. Dr. Michael L. Krychman from Southern California Center for...

2014-01-27 12:29:17

Nearly two-thirds of women polled believe it's inappropriate that the score is 24-0 when it comes to federal approval of treatments for desire, arousal or orgasm dysfunction in men vs. women WASHINGTON, Jan. 27, 2014 /PRNewswire-USNewswire/ -- Almost two-thirds of American women believe that society places a greater emphasis on addressing men's sexual satisfaction than on women's - an opinion underscored by the fact that 24 drugs have received federal approval to treat male sexual...

2014-01-26 23:02:25

Medical and Therapeutic Sexual Treatments for Men, Women and Couples New York, NY (PRWEB) January 26, 2014 According to the Journal of Sexual medicine, 16% of couples face constant sexual dysfunction in their relationship. Studies show that sexual issues facing couples are more effectively overcome when treating the couple rather than the individual. Dr. Jed Kaminetsky, a renown Manhattan-based Urologist, formed the Manhattan Sexual Health and Wellness (MSHW) to provide critical...


Word of the Day
malpais
  • The ragged surface of a lava-flow.
'Malpais' translates from Spanish as 'bad land.'